Microplastics and Nanoplastics: What We Know About Sources, Body Burden, and Emerging Health Risks

Visualization of Microplastics and Nanoplastics environmental source
Visualization of Microplastics and Nanoplastics environmental source.
Microscopic view of Microplastics and Nanoplastics cellular damage
Microscopic view of Microplastics and Nanoplastics cellular damage.
Anatomical illustration of organs affected by Microplastics and Nanoplastics exposure
Anatomical illustration of organs affected by Microplastics and Nanoplastics exposure.

Microplastics — plastic particles from 1 µm up to 5 mm — and their smaller siblings nanoplastics (smaller than 1 µm) have been measured in water, food, air and dust, and in a growing list of human tissues. Studies since 2019 have reported plastic particles in stool, blood, lungs, placenta, breast milk, testes, liver, kidney, brain and atherosclerotic plaque. A 2024 observational study in the New England Journal of Medicine reported that patients whose carotid-artery plaque contained micro- and nanoplastics had a hazard ratio of 4.53 for heart attack, stroke or death over a mean of about 34 months. The field is young: measurement methods are still being validated, most findings come from single studies, and official assessments describe the information as too limited to settle whether current exposure affects health.

This article covers what microplastics and nanoplastics are, where exposure comes from, how intake has been estimated, what has been found in the body, the health associations reported so far, the open questions, and the regulatory actions taken.

Table of Contents

  1. What Microplastics and Nanoplastics Are
  2. Major Exposure Sources
  3. How Much Are We Actually Taking In?
  4. Body Burden — What Has Been Found and Where
  5. Emerging Health Associations
  6. Proposed Mechanisms
  7. What We Do Not Know, Stated Plainly
  8. Official Assessments and Regulation
  9. What Studies Report About Lowering Exposure
  10. Claims the Evidence Does Not Support
  11. Testing: What Exists and What Does Not
  12. Pregnancy, Infants and Higher-Exposure Groups
  13. Key Research Papers
  14. Connections
  15. Featured Videos

What Microplastics and Nanoplastics Are

Microplastics are plastic particles from about 1 µm to 5 mm — from the size of a sesame seed down to invisibility. Nanoplastics are smaller than 1 µm. Size decides what a particle can do in the body. The World Health Organization’s 2019 drinking-water report described particles larger than 150 µm as unlikely to be absorbed, uptake of smaller particles as expected to be limited, and data on the absorption of nano-sized particles as extremely scarce.

Particle counts and mass estimates tell very different stories. A 2026 tissue-imaging study of human placenta found that 73% of the particles it detected were smaller than 1 µm; the authors noted that this number-dominant fraction carries so little mass that it falls below the detection limits of the bulk pyrolysis methods most tissue studies use (Wouters 2026). The smallest particles are the hardest to measure, and they are the ones most able to cross biological barriers in laboratory and animal studies.

They come in two categories by origin:

Chemically they are not one substance. Polyethylene, polypropylene, polyvinyl chloride, polystyrene, polyethylene terephthalate and polyamide behave differently, carry different additives, and adsorb different contaminants from their surroundings. Studies that report “microplastics” as a single exposure are aggregating a chemically diverse mixture, which is one of the main reasons the health literature is hard to synthesise.

Major Exposure Sources

Exposure happens by three routes — ingestion, inhalation and, to a much lesser degree, skin contact.

Drinking water

Food

Air and dust

How Much Are We Actually Taking In?

The best-known figure is that people swallow “a credit card a week” — about 5 g of plastic. It was publicised by WWF in 2019 from an analysis by researchers at the University of Newcastle, Australia, later published in peer-reviewed form.

That paper, Senathirajah and colleagues (Journal of Hazardous Materials, 2021; one co-author was affiliated with WWF), extracted data from 59 publications, converted particle counts to mass, and estimated that humans may ingest on average 0.1–5 g of microplastics per week. The credit-card figure is the top of that range.

Other estimates are far lower. A 2021 probabilistic lifetime model by Mohamed Nor and colleagues (Environmental Science & Technology), covering eight food types plus inhalation and particles of 1–5,000 µm, estimated median intakes of 883 particles (583 ng) per day for adults and 553 particles (184 ng) per day for children, and found that its simulated stool concentrations agreed with measured data. An earlier count-based estimate by Cox and colleagues (Environmental Science & Technology, 2019), covering about 15% of Americans’ caloric intake, put annual consumption at 39,000 to 52,000 particles depending on age and sex, rising to 74,000–121,000 when inhalation was included; the authors described their figures as likely underestimates.

All of these are models built on incomplete sampling of a small number of foods, and they disagree with one another by large margins. Intake is real and measurable; a precise weekly mass is not known.

Body Burden — What Has Been Found and Where

Since 2019 studies have moved from estimating exposure to measuring particles in human samples. Plastic particles have been reported in:

How reliable are these numbers? Contamination during collection and analysis is a serious problem: plastic labware, laboratory air and clothing all shed particles. A 2026 screening of 133 datasets from 101 studies of microplastics in human organs, tissues and fluids found that none met all essential quality-assurance criteria; the authors judged the current value of these data to lie mainly in pioneering exploratory research, and wrote that some findings warrant careful evaluation of biological plausibility (Lane 2026). A specific concern applies to Py-GC-MS, the method behind the blood, plaque, brain, placenta and testis mass figures: reviews of the method describe interference from lipids in measuring polyethylene in biological samples as a recognised problem (Almeida 2026; Zhang 2026). The brain-study authors wrote that their potassium-hydroxide digestion was designed to reduce that concern.

Emerging Health Associations

The cardiovascular finding

The most widely cited human outcome study is Marfella and colleagues in the New England Journal of Medicine (2024). They enrolled 304 patients undergoing carotid endarterectomy for asymptomatic carotid artery disease in Italy; 257 completed a mean follow-up of 33.7 months. Polyethylene was detected in the plaque of 150 patients (58.4%) and polyvinyl chloride in 31 (12.1%). Patients whose plaque contained micro- and nanoplastics had a hazard ratio of 4.53 (95% confidence interval 2.00 to 10.27) for the composite of heart attack, stroke or death from any cause, compared with patients whose plaque did not.

Its limits are part of the finding:

Everything else

Beyond cardiovascular disease, human outcome evidence is largely absent. There are laboratory and animal findings on inflammation, oxidative stress, gut barrier disruption, altered microbiome and reproductive effects. An expert review of mammalian studies for California found that 83% of the prioritised studies used a single polymer type (polystyrene spheres), which resemble weathered environmental fragments only loosely (Coffin 2022).

The World Health Organization’s 2019 assessment found no indication of a health risk from microplastics in drinking water at current levels while describing the information as limited, and a 2022 expert review for California could not set a health-based threshold (see Official Assessments and Regulation). The evidence is not settled in either direction.

Proposed Mechanisms

These are plausible and partly demonstrated in laboratory systems; none is confirmed as operating in humans at real-world doses.

  1. Physical and inflammatory irritation. Particles taken up by macrophages that cannot digest them are proposed to drive chronic low-grade inflammation. In the plaque study, electron microscopy showed jagged-edged foreign particles among plaque macrophages.
  2. Oxidative stress. Across the mammalian toxicity studies reviewed for California, biomarkers of inflammation and oxidative stress were the most consistent trend (Coffin 2022).
  3. Chemical carrier effect. Plastics carry additives put in during manufacture — phthalate plasticisers, bisphenols, flame retardants, stabilisers — several of which are studied as endocrine disruptors in their own right. They also adsorb persistent organic pollutants and metals from the environment. How much this adds is debated: the 2021 lifetime model estimated that the contribution of ingested microplastics to total chemical intake is small compared with food itself (Mohamed Nor 2021).
  4. Microbiome disruption. Particles and their additives can alter gut bacterial communities in animal models.
  5. Barrier crossing. Nanoplastics have been reported in animal studies to cross the gut, placental and blood–brain barriers; the human evidence is currently detection in those tissues rather than demonstrated transport.

What We Do Not Know, Stated Plainly

The human evidence climbs only part of the way from “found in the body” to “causes harm”:

A four-rung evidence ladder for microplastics in people. The bottom rung, detected in human tissue, is filled: particles have been reported in blood, placenta, lung, testis, brain and plaque, although a 2026 review found none of 101 studies met all essential quality criteria. The second rung, associated with disease, is partly filled by one observational plaque study with a hazard ratio of 4.53 in 257 patients and a post-mortem brain comparison of 12 dementia cases. The third rung, shown to cause harm in humans, and the top rung, shown that lowering exposure helps, are empty outlines: no such study exists. THE EVIDENCE LADDER how far the human data on microplastics reach · bottom to top 4 · LOWERING EXPOSURE HELPS no intervention trial exists for any health outcome 3 · SHOWN TO CAUSE HARM IN PEOPLE no dose–response, no causal study; animal and cell work only 2 · ASSOCIATED WITH DISEASE one plaque study: hazard ratio 4.53, 257 patients post-mortem brains: higher in 12 dementia cases 1 · DETECTED IN HUMAN TISSUE blood, placenta, lung, testis, brain, plaque none of 101 studies met all essential QA criteria WHAT EACH RUNG NEEDS detection is not exposure measured well contamination and lipid interference can inflate counts association is not cause people with more plastic may differ in other ways an empty rung is not proof of safety it means the study has not been done the human data stop at the second rung: harm is neither shown nor ruled out at current exposures.

These gaps cut both ways: the data neither establish harm at current exposures nor rule it out. No study supports “detox” products as a response to the uncertainty (see Claims the Evidence Does Not Support).

Official Assessments and Regulation

What Studies Report About Lowering Exposure

No study has tested whether lowering microplastic intake changes any health outcome. What exists are measurements of which sources release the most particles and which conditions increase release:

Claims the Evidence Does Not Support

Testing: What Exists and What Does Not

Measurement of microplastics in people is a research technique — pyrolysis gas chromatography–mass spectrometry, Raman or FTIR microscopy, in a contamination-controlled laboratory. It is not available as a validated clinical test, there is no normal range to compare a result against, and there is no treatment that a result would change. A consumer body-burden result therefore has no established clinical meaning.

Water samples are a different matter from tissue: they can be analysed with the same research methods used in the studies above. Results depend heavily on the method: the 2024 nanoplastic counts in bottled water required a newly developed imaging platform, and earlier counts covered microplastics only (Qian 2024).

Pregnancy, Infants and Higher-Exposure Groups

The groups the research describes as more exposed, or as exposed at more sensitive stages of life:

Decisions about individual health concerns belong with a clinician.

↑ Back to Table of Contents

Key Research Papers

Each citation below was checked against its PubMed record; the linked DOI resolves to the paper named. This is a fast-moving field, and several of these papers are single studies awaiting replication — that is noted where it applies, along with published corrections and critiques.

  1. Marfella R, Prattichizzo F, Sardu C, et al. Microplastics and nanoplastics in atheromas and cardiovascular events. N Engl J Med. 2024;390(10):900–910. — doi:10.1056/NEJMoa2309822 · PubMed PMID: 38446676 — observational; letters to the journal and an authors’ reply followed (reply: PubMed PMID: 38718368).
  2. Leslie HA, van Velzen MJM, Brandsma SH, et al. Discovery and quantification of plastic particle pollution in human blood. Environ Int. 2022;163:107199. — doi:10.1016/j.envint.2022.107199 ( PubMed PMID: 35367073)
  3. Ragusa A, Svelato A, Santacroce C, et al. Plasticenta: first evidence of microplastics in human placenta. Environ Int. 2021;146:106274. — doi:10.1016/j.envint.2020.106274 ( PubMed PMID: 33395930)
  4. Nihart AJ, Garcia MA, El Hayek E, et al. Bioaccumulation of microplastics in decedent human brains. Nat Med. 2025;31(4):1114–1119. — doi:10.1038/s41591-024-03453-1 · PubMed PMID: 39901044 — post-mortem association; direction of causation unknown. Author correction 2025 (duplicated supplementary images, scale bars): PubMed PMID: 40164728.
  5. Qian N, Gao X, Lang X, et al. Rapid single-particle chemical imaging of nanoplastics by SRS microscopy. Proc Natl Acad Sci U S A. 2024;121(3):e2300582121. — doi:10.1073/pnas.2300582121 · PubMed PMID: 38190543 — the bottled-water nanoplastic counts.
  6. Zhao Q, Zhu L, Weng J, et al. Detection and characterization of microplastics in the human testis and semen. Sci Total Environ. 2023;877:162713. — doi:10.1016/j.scitotenv.2023.162713 ( PubMed PMID: 36948312)
  7. Cox KD, Covernton GA, Davies HL, et al. Human consumption of microplastics. Environ Sci Technol. 2019;53(12):7068–7074. — doi:10.1021/acs.est.9b01517 ( PubMed PMID: 31184127) — a correction was published in 2020 (PubMed PMID: 32804499).
  8. Senathirajah K, Attwood S, Bhagwat G, et al. Estimation of the mass of microplastics ingested — a pivotal first step towards human health risk assessment. J Hazard Mater. 2021;404(Pt B):124004. — doi:10.1016/j.jhazmat.2020.124004 · PubMed PMID: 33130380 — the source of the “credit card a week” figure, at the top of a 0.1–5 g/week range.
  9. Vethaak AD, Legler J. Microplastics and human health. Science. 2021;371(6530):672–674. — doi:10.1126/science.abe5041 ( PubMed PMID: 33574197)
  10. Coffin S, Bouwmeester H, Brander S, et al. Development and application of a health-based framework for informing regulatory action in relation to exposure of microplastic particles in California drinking water. Microplast Nanoplast. 2022;2(1):12. — doi:10.1186/s43591-022-00030-6 ( PubMed PMID: 35634037) — a correction notice was published in 2022 (doi:10.1186/s43591-022-00039-x).
  11. Mohamed Nor NH, Kooi M, Diepens NJ, Koelmans AA. Lifetime accumulation of microplastic in children and adults. Environ Sci Technol. 2021;55(8):5084–5096. — doi:10.1021/acs.est.0c07384 · PubMed PMID: 33724830 — a far lower intake estimate than the credit-card figure.
  12. Lane T, de Ruijter VN, Wardani I, Barchiesi M, Koelmans AA. A QA/QC screening framework to assess studies reporting microplastic presence in human organs, tissues, and bodily fluids. Environ Int. 2026;214:110429. — doi:10.1016/j.envint.2026.110429 · PubMed PMID: 42503274
  13. Almeida FN, Leray C, Albignac M, et al. Py-GC-MS/MS quantification of microplastics in vertebrate tissues: addressing false positives of polyethylene. J Hazard Mater. 2026;501:140658. — doi:10.1016/j.jhazmat.2025.140658 · PubMed PMID: 41352016 — a seabird study; cited for the lipid-interference problem it addresses.
  14. Zhang Y, Liu Y, Li G, et al. Thermal analysis techniques for microplastic mass quantification: methodological challenges and standardization needs. Talanta. 2026;310:130095. — doi:10.1016/j.talanta.2026.130095 · PubMed PMID: 42275720
  15. Wouters Q, Abakumov S, Van Der Stukken C, et al. Hydrogel transformation reveals a conventionally inaccessible sub-micrometer microplastic fraction in intact human tissues. ACS Nano. 2026;20(34):24123–24134. — doi:10.1021/acsnano.6c12376 · PubMed PMID: 42689720
  16. Garcia MA, Liu R, Nihart A, et al. Quantitation and identification of microplastics accumulation in human placental specimens using pyrolysis gas chromatography mass spectrometry. Toxicol Sci. 2024;199(1):81–88. — doi:10.1093/toxsci/kfae021 · PubMed PMID: 38366932
  17. Hu CJ, Garcia MA, Nihart A, et al. Microplastic presence in dog and human testis and its potential association with sperm count and weights of testis and epididymis. Toxicol Sci. 2024;200(2):235–240. — doi:10.1093/toxsci/kfae060 · PubMed PMID: 38745431 — a published comment and the authors’ response followed (response: PubMed PMID: 39432568).
  18. Jenner LC, Rotchell JM, Bennett RT, et al. Detection of microplastics in human lung tissue using µFTIR spectroscopy. Sci Total Environ. 2022;831:154907. — doi:10.1016/j.scitotenv.2022.154907 · PubMed PMID: 35364151
  19. Ragusa A, Notarstefano V, Svelato A, et al. Raman microspectroscopy detection and characterisation of microplastics in human breastmilk. Polymers (Basel). 2022;14(13):2700. — doi:10.3390/polym14132700 · PubMed PMID: 35808745
  20. Schwabl P, Köppel S, Königshofer P, et al. Detection of various microplastics in human stool: a prospective case series. Ann Intern Med. 2019;171(7):453–457. — doi:10.7326/M19-0618 · PubMed PMID: 31476765
  21. Hernandez LM, Xu EG, Larsson HCE, et al. Plastic teabags release billions of microparticles and nanoparticles into tea. Environ Sci Technol. 2019;53(21):12300–12310. — doi:10.1021/acs.est.9b02540 · PubMed PMID: 31552738 — a published comment (PubMed PMID: 33052042) and the authors’ reply (PubMed PMID: 33064472).
  22. Hussain KA, Romanova S, Okur I, et al. Assessing the release of microplastics and nanoplastics from plastic containers and reusable food pouches: implications for human health. Environ Sci Technol. 2023;57(26):9782–9792. — doi:10.1021/acs.est.3c01942 · PubMed PMID: 37343248 — published correspondence (PubMed PMID: 38722707) and the authors’ rebuttal (PubMed PMID: 38722646).
  23. Li D, Shi Y, Yang L, et al. Microplastic release from the degradation of polypropylene feeding bottles during infant formula preparation. Nat Food. 2020;1(11):746–754. — doi:10.1038/s43016-020-00171-y · PubMed PMID: 37128027
  24. Yadav H, Khan MRH, Quadir M, et al. Cutting boards: an overlooked source of microplastics in human food? Environ Sci Technol. 2023;57(22):8225–8235. — doi:10.1021/acs.est.3c00924 · PubMed PMID: 37220346
  25. Dris R, Gasperi J, Mirande C, et al. A first overview of textile fibers, including microplastics, in indoor and outdoor environments. Environ Pollut. 2017;221:453–458. — doi:10.1016/j.envpol.2016.12.013 · PubMed PMID: 27989388
  26. Kole PJ, Löhr AJ, Van Belleghem FGAJ, Ragas AMJ. Wear and tear of tyres: a stealthy source of microplastics in the environment. Int J Environ Res Public Health. 2017;14(10):1265. — doi:10.3390/ijerph14101265 · PubMed PMID: 29053641
  27. Napper IE, Thompson RC. Release of synthetic microplastic plastic fibres from domestic washing machines: effects of fabric type and washing conditions. Mar Pollut Bull. 2016;112(1–2):39–45. — doi:10.1016/j.marpolbul.2016.09.025 · PubMed PMID: 27686821
  28. Kern DG, Kuhn C, Ely EW, et al. Flock worker's lung: broadening the spectrum of clinicopathology, narrowing the spectrum of suspected etiologies. Chest. 2000;117(1):251–259. — doi:10.1378/chest.117.1.251 · PubMed PMID: 10631226

Official Reports

  1. World Health Organization. Microplastics in drinking-water. Geneva: WHO; 2019. — who.int/publications/i/item/9789241516198
  2. World Health Organization. Dietary and inhalation exposure to nano- and microplastic particles and potential implications for human health. Geneva: WHO; 2022. — who.int/publications/i/item/9789240054608
  3. European Commission. Commission Regulation (EU) 2023/2055 — restriction of microplastics intentionally added to products. — single-market-economy.ec.europa.eu

PubMed Topic Searches

These queries surface current peer-reviewed work as it is indexed.

  1. PubMed: Search: microplastics human health
  2. PubMed: Search: nanoplastics toxicity
  3. PubMed: Search: microplastics cardiovascular disease
  4. PubMed: Search: microplastics bottled water
  5. PubMed: Search: microplastics placenta breast milk
  6. PubMed: Search: microplastics infant feeding bottles
  7. PubMed: Search: microplastics indoor air dust
  8. PubMed: Search: microplastics gut microbiome
  9. PubMed: Search: plastic additives endocrine disruption
  10. PubMed: Search: microplastics sample contamination controls

↑ Back to Table of Contents

Connections

↑ Back to Table of Contents

Microplastics — scientific infographic poster